Previous Advocacy Updates

Pathologists will have new opportunities to earn incentives for participating in quality initiatives while never having to face another SGR cut again.

The Senate passed a SGR repeal bill that includes a CAP provision to ensure pathologists can more easily comply with Medicare quality initiatives.

The CAP called on the Senate to pass legislation that repeals the Medicare SGR and ensures pathologists can fully participate in a new pay system.

The CAP continues to engage with UnitedHealthcare and oppose the insurer’s Florida laboratory benefit management pilot program that uses BeaconLBS.

The CAP urged Noridian to rescind a draft LCD on special stains because its base evidence is unsubstantiated and it encroaches on medical judgment.

The College of American Pathologists (CAP) applauds the House for its passage of HR 2, the Medicare Access and CHIP Reauthorization Act, the bipartisan, bicameral legislation which includes the CAP secured language that gives pathologists much needed flexibility in Medicare's quality initiatives.

The CAP and pathologists in Florida strongly oppose UnitedHealthcare’s Beacon pilot program and remain engaged with the insurer over several concerns.

Citing concerns that purported evidence lacks credibility, the CAP continues to vigorously oppose a Medicare LCD on special IHC stains.

Significant changes are needed to the Food and Drug Administration draft guidance on oversight of LDTs, the CAP said during testimony at an FDA forum.